TradingView
dasranc777
Jun 23, 2022 11:57 AM
$HEM grants universal field license to PreCerv Inc.
TSXV:HEM
1D
HEMOSTEMIX INC
TSXV
Description
⋅
Jun 23, 2022 11:57 AM
Hemostemix recently granted the global field license of use of NCP-01 and its autologous stem cell therapies to PreCerv Inc. its wholly owned subsidiary to aid patients with peripheral and central nervous system conditions.
Trend Analysis
Stocks
More